Bortezomib will improve the amount or result of flibanserin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Elevated flibanserin adverse effects may perhaps arise if coadministered with multiple weak CYP3A4 inhibitors. levoketoconazole will increase the degree or outcome of bortezomib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Cautio... https://cgp2071235791.blogginaway.com/27286719/fascination-about-2